About: In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 July 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в липні 2016 (uk) scientific article published on 11 July 2016 (en) 2016 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված (hy) مقالة علمية نشرت في 11 يوليو 2016 (ar)
publication date	wds:Q37203885-37493E87-A75A-4230-BE87-0789C3F62C9A
publication date	2016-07-11 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37203885-4E9A3499-D83B-4A99-AEBD-6F6C5B21C5A1
language of work or name	English
cites work	wds:Q37203885-0CDB7590-D5A9-4B00-A6BF-1EC9FC63B7BB wds:Q37203885-12570F4E-6E4A-4908-A7BC-320228256E3B wds:Q37203885-1B4D08AF-FAC5-4AA2-B278-0928DFD37849 wds:Q37203885-1F6415DE-99D4-4DFD-8F3E-8A189ACE3C70 wds:Q37203885-4645D861-A52B-4CCE-B28E-4541CF6BB56A wds:Q37203885-4B545DE5-E4B6-423C-8F47-B8407C8756C3 wds:Q37203885-52A6DBED-9400-4B39-8BCC-376BBC1CEF24 wds:Q37203885-5873E975-3533-402C-A408-266D22694725 wds:Q37203885-59FD1B44-4042-4BFF-A5D1-9C32450422F5 wds:Q37203885-5FA55BD4-46E4-4EF5-B73E-1E2755C8D51B wds:Q37203885-6F4768D9-3597-4CC0-A913-E2B08E935650 wds:Q37203885-71755428-AC13-4BF6-B544-3B0D9BB921A3 wds:Q37203885-739E1552-5C18-4F19-BB71-1419DDAE7FF8 wds:Q37203885-7698CDEB-A6A1-4986-9A0B-E4227A5E95D5 wds:Q37203885-8E0F81AF-65FD-4BA9-82A2-6647623DB4FD wds:Q37203885-92BB778C-1495-45D9-A237-896F50A2D9C5 wds:Q37203885-9EC26F59-41BF-45F3-9B28-2F95AFE3D75F wds:Q37203885-A59FF9D6-1C43-47B0-8468-915F870D4990 wds:Q37203885-A5A65EAF-4FF9-45E5-9A51-6BBF404C19FA wds:Q37203885-AC9FF47F-30E7-43DE-BE4A-D396A44CA772 wds:Q37203885-B03296FA-C557-4C51-AC0A-C369E195D334 wds:Q37203885-B6F17206-C686-433E-B61F-4AB632921732 wds:Q37203885-C252B085-2523-4999-922A-27A46E897DE3 wds:Q37203885-C4A19539-F161-44F5-83F8-194ADDCCB453 wds:Q37203885-D563143C-E9BC-4052-AF56-D1F8BF5CD9AD wds:Q37203885-E4715BC6-0F1C-44A2-A906-A290A7F27BD7 wds:Q37203885-F046C996-B31D-437C-A4D9-CFF14349DECA wds:Q37203885-FC914988-6ED7-4E6B-9AC8-43FFE3AAE44B wds:Q37203885-FD0326E2-1B68-4BD6-80FA-20B764B0ABBF wds:Q37203885-FD31758E-3EEB-4FBC-A364-B63CACC9C6E6
cites work	An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci Linezolid resistance in a clinical isolate of Staphylococcus aureus Comparative genomics of Staphylococcus aureus musculoskeletal isolates. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall Antibiotic interactions that select against resistance. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin Postantibiotic suppression of bacterial growth Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics Structure-activity relationship for the oxadiazole class of antibiotics. Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study The future of the β-lactams. Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses Evolving resistance among Gram-positive pathogens β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline Ceftaroline-heteroresistant Staphylococcus aureus Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
author name string	wds:Q37203885-11360A02-04B9-4AB7-90AC-6E8596280F1F wds:Q37203885-3C7222EB-99F8-4B4A-8937-C073F9BFFF29 wds:Q37203885-4F7A60DD-B743-41AD-A230-E77D1BEB9908 wds:Q37203885-C3C3F3C6-18B6-4F62-9E00-81A07C2C7024 wds:Q37203885-FD3E64FF-8BE4-4130-80CA-06638EFA73DC
author name string	Derong Ding Jeshina Janardhanan Jayda E Meisel Valerie A Schroeder William R Wolter
rdfs:label	In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (en) In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (nl) In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (ast)
skos:prefLabel	In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (en) In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (nl) In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (ast)
name	In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software